Greg J. Reinhart

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “In Vitro Pharmacological Characterization of CRN04894: The First Reported Oral, Selective Nonpeptide Melanocortin 2 Receptor Antagonist Evaluated in Phase 1 First‐in‐Human Clinical Trials”.

In Vitro Pharmacological Characterization of CRN04894: The First Reported Oral, Selective Nonpeptide Melanocortin 2 Receptor Antagonist Evaluated in Phase 1 First‐in‐Human Clinical Trials

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r2027

N/A

0DataRank · unranked

2 citations

Ana Karin Kusnetzow, Greg J. Reinhart, Sun Hee Kim, R. Scott Struthers, Yun Zhu +2 more

Discovery of CRN04894: A Novel Potent Selective MC2R Antagonist

ACS Medicinal Chemistry Letters(2024)10.1021/acsmedchemlett.3c00514

N/A

0DataRank · unranked

13 citations

Sangdon Han, Jian Zhao, Shimiao Wang, Ana Karin Kusnetzow, Greg J. Reinhart +8 more